147
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Abdominal Fat Is Directly Associated With Inflammation In Persons With Type-2 Diabetes Regardless Of Glycemic Control – A Jordanian Study

ORCID Icon, , ORCID Icon, , &
Pages 2411-2417 | Published online: 22 Nov 2019

References

  • Ajlouni K , Khader Y , Batieha A , Ajlouni H , El-Khateeb M . An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications . 2008;22(5):317–324. doi:10.1016/j.jdiacomp.2007.01.004 18413210
  • Khader YS , Batieha A , El-Khateeb M , Al Omari M , Ajlouni K . Prevalence of dyslipidemia and its associated factors among Jordanian adults. J Clin Lipidol . 2010;4(1):53–58. doi:10.1016/j.jacl.2009.12.004 21122627
  • Mubarak FM , Froelicher ES , Jaddou HY , Ajlouni KM . Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan. Ann Saudi Med . 2008;28(5):346–351. doi:10.5144/0256-4947.2008.346 18779643
  • Gabay C . Interleukin-6 and chronic inflammation. Arthritis Res Ther . 2006;8(2):S3. doi:10.1186/ar1917
  • Baniyash M . Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol . 2006;16(1):80–88. doi:10.1016/j.semcancer.2005.12.002 16420981
  • Porta C , Larghi P , Rimoldi M , et al. Cellular and molecular pathways linking inflammation and cancer. Immunobiology . 2009;214(9–10):761–777. doi:10.1016/j.imbio.2009.06.014 19616341
  • Wang X , Bao W , Liu J , et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care . 2013;36(1):166–175. doi:10.2337/dc12-0702 23264288
  • Donath M , Ehses J , Maedler K , et al. Mechanisms of β-cell death in type 2 diabetes. Diabetes . 2005;54(2):108–113. doi:10.2337/diabetes.54.suppl_2.S108
  • Maedler K , Sergeev P , Ris F , et al. Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest . 2002;110(6):851–860. doi:10.1172/JCI15318 12235117
  • Meier J . Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia . 2008;51(5):703–713. doi:10.1007/s00125-008-0936-9 18317728
  • Robertson R . Chronic oxidative stress as a cenetral mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem . 2004;279(41):42351–42354. doi:10.1074/jbc.R400019200 15258147
  • Freeman D , Norrie J , Caslake M , et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes . 2002;51(5):1596–1600. doi:10.2337/diabetes.51.5.1596 11978661
  • Osborn O , Olefsky J . The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med . 2012;18(3):363–374. doi:10.1038/nm.2627 22395709
  • Tanigaki K , Vongpatanasin W , Barrera J , et al. C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB–mediated inhibition of skeletal muscle glucose delivery. Diabetes . 2013;62(3):721–731. doi:10.2337/db12-0133 23069625
  • Heilbronn L , Campbell L . Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des . 2008;14(12):1225–1230. doi:10.2174/138161208784246153 18473870
  • Schenk S , Saberi M , Olefsky J . Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest . 2008;118(9):2992–3002. doi:10.1172/JCI34260 18769626
  • Dandona P , Aljada A , Chaudhuri A , Bandyopadhyay A . The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes. J Clin Endocrinol Metab . 2003;88(6):2422–2429. doi:10.1210/jc.2003-030178 12788837
  • Lu H , Raptis M , Black E , Stan M , Amar S , Graves D . Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology . 2004;145(11):4934–4939. doi:10.1210/en.2004-0737 15284196
  • Wegner M , Araszkiewicz A , Piorunska-Stolzmann M , Wierusz-Wysocka B , Zozulinska-Ziolkiewicz D . Association between IL-6 concentration and diabetes-related variables in DM1 patients with and without microvascular complications. Inflammation . 2013;36(3):723–728. doi:10.1007/s10753-013-9598-y 23371411
  • Rashad N , El-Shabrawy R , Sabry H , Fathy H , Said D , Yousef M . Interleukin-6 and hs-CRP as early diagnostic biomarkers for obesity-related peripheral polyneuropathy in non-diabetic patients. Egypt J Immunol . 2018;25(2):153–165.
  • World Health Organization. Obesity: Preventing and Managing the Global Epidemic . World Health Organization; 2000.
  • Rutherford W , Diemer G , Scott E . Comparison of Bioelectrical Impedance and Skinfolds with Hydrodensitometry in the Assessment of Body Composition in Healthy Young Adults. J Res . 2011;6(2):56–60.
  • Gallagher D , Heymsfield S , Heo M , Jebb S , Murgatroyd P , Sakamoto Y . Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr . 2000;72(3):694–701. doi:10.1093/ajcn/72.3.694 10966886
  • Lin Y , Rajala M , Berger J , Moller D , Barzilai N , Scherer P . Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem . 2001;276(45):42077–42083. doi:10.1074/jbc.M107101200 11546817
  • Bulló M , Casas-Agustench P , Amigó-Correig P , Aranceta J , Salas-Salvadó J . Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr . 2007;10(10A):1164–1172. doi:10.1017/S1368980007000663 17903326
  • Yudkin J , Kumari M , Humphries S , Mohamed-Ali V . Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis . 2000;148(2):209–214. doi:10.1016/s0021-9150(99)00463-3 10657556
  • Ray I , Mahata S , De R . Obesity: an immunometabolic perspective. Front Endocrinol (Lausanne) . 2016;7(157). doi:10.3389/fendo.2016.00089
  • Yuan T , Yang T , Chen H , et al. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol . 2018;20:247–260.30384259
  • Halim M , Halim A . The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabet Metab Syndr . 2019;13:1165–1172. doi:10.1016/j.dsx.2019.01.040
  • Mohan V , Deepa R , Velmurugan K , Premalatha G . Association of C‐reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES‐6). Diabet Med . 2005;22(7):863–870. doi:10.1111/j.1464-5491.2005.01541.x 15975100
  • Začiragić A , Hadžović-Džuvo A , Valjevac A , Avdagić N , Mulabegović N . Serum C-reactive protein concentration and measures of adiposity in patients with type 2 diabetes mellitus. Bosn J Basic Med Sci . 2007;7(4):322–327. doi:10.17305/bjbms.2007.3021 18039190
  • Rawson E , Freedson P , Osganian S , Matthews C , Reed G , Ockene I . Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc . 2003;35(7):1160–1166. doi:10.1249/01.MSS.0000074565.79230.AB 12840637
  • Axelsson J , Rashid Qureshi A , Suliman M , et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr . 2004;80(5):1222–1229. doi:10.1093/ajcn/80.5.1222 15531669
  • Festa A , D’Agostino R , Williams K , et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes . 2001;25(10):1407–1415. doi:10.1038/sj.ijo.0801792
  • Vega GL , Adams-Huet B , Peshock R , Willett D , Shah B , Grundy S . Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab . 2006;91(11):4459–4466. doi:10.1210/jc.2006-0814 16926254
  • Hammett C , Oxenham H , Baldi J , et al. Effect of six months’ exercise training on C-reactive protein levels in healthy elderly subjects. J Am Coll Cardiol . 2004;44(12):2411–2413. doi:10.1016/j.jacc.2004.09.030 15607408
  • Nadeem A , Naveed A , Hussain M , Raza S . Correlation of inflammatory markers with type 2 Diabetes Mellitus in Pakistani patients. J Postgrad Med Inst . 2013;27(3):367–373.
  • Park H , Park J , Yu R . Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Res Clin Pract . 2005;69(1):29–35. doi:10.1016/j.diabres.2004.11.007 15955385
  • Rexrode K , Pradhan A , Manson J , Buring J , Ridker P . Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol . 2003;13(10):674–682.14599731
  • Pedersen M , Bruunsgaard H , Weis N , et al. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech Ageing Dev . 2003;124(4):495–502. doi:10.1016/s0047-6374(03)00027-7 12714258
  • Bastard J , Maachi M , Van Nhieu J , et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab . 2002;87(5):2048–2049. doi:10.1210/jcem.87.5.8450
  • Lafontan M , Berlan M . Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci . 2003;24(6):276–283. doi:10.1016/S0165-6147(03)00132-9 12823953
  • Hoffman R , Dye A , Huang H , Bauer J . Glycemic variability predicts inflammation in adolescents with type 1 diabetes. J Pediatr Endocrinol Metab . 2016;29(10):1129–1133. doi:10.1515/jpem-2016-0139 27658133
  • Dal S , Jeandidier N , Seyfritz E , et al. Featured article: oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy. Exp Biol Med . 2016;241(2):184–192. doi:10.1177/1535370215603837
  • Monnier L , Mas E , Ginet C , et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. Jama . 2006;295(14):1681–1687. doi:10.1001/jama.295.14.1681 16609090